Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > European Human Growth Hormones Market
Category
Pharmaceutical (4988)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (561)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

European Human Growth Hormones Market

Published by Frost & Sullivan
Published August, 2008 Product code 71249
Content info  
Price
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


European Human Growth Hormones Market published by Frost & Sullivan in August, 2008. This report price starts from US $ 6500.

Introduction

Abstract

This research service give a detailed analysis of the European hGH market from 2007 to 2014. The effect of various drivers and challenges for the hGH market are discussed and revenue forecasts provided based on market dynamics. Reimbursements issues and approval processes are described. Revenue forecasts include revenues by each country in Europe. Strategic recommendations are provided for the various challenges facing LIMS vendors in the European market.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary for European hGH Market
    • 1. Industry Snapshot

2 GLOSSARY AND EXCHANGE RATES

  • Glossary
    • 1. Glossary of Terms
  • Exchange Rates
    • 1. Exchange Rates for the Total European Human Growth Hormones Market

3 INDUSTRY CHALLENGES

  • Identification of Key Industrial Challenges Facing the Total European hGH Market
    • 1. Key Industry Challenges

4 EUROPEAN HUMAN GROWTH HORMONES MARKET

  • Total European Human Growth Hormones Market
    • 1. Product Overview
    • 2. Disease Overview
    • 3. Research Methodology
    • 4. Market Segmentation
    • 5. Measurements
    • 6. Market Drivers
    • 7. Market Restraints
    • 8. Revenue Forecasting Analysis
    • 9. Market and Pricing Trends
    • 10. Competitive Analysis

5 DEMOGRAPHIC ANALYSIS

  • Geographical Trends
    • 1. Overview
    • 2. The United Kingdom
    • 3. Germany
    • 4. France
    • 5. Spain
    • 6. Italy
    • 7. Benelux
    • 8. Scandinavia

6 PIPELINE ANALYSIS

  • Pipeline Review
    • 1. Recent Clinical Developments

7 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN HGH MARKET

  • Strategic Recommendations
    • 1. Strategic Recommendations

8 DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Industry Participants
    • 1. Key Industry Participants

9 DECISION SUPPORT DATABASE FOR EUROPEAN HGH MARKET

  • Decision Support Database Tables
    • 1. Total Pharmaceutical R&D Expenditures
    • 2. Government Biotechnology R&D Database
    • 3. Venture Capital Investment in Biotechnology R&D
    • 4. Total Healthcare Expenditure
    • 5. Total Number of Biotechology Companies
Back to Top